RATIONALE: The serotonin 7 receptor (5-HT7-R) is part of a neuro-transmission system with a proposed role in neural plasticity and in mood, cognitive or sleep regulation. OBJECTIVES: We investigated long-term consequences of sub-chronic treatment, during adolescence (43-45 to 47-49 days old) in rats, with a novel 5-HT7-R agonist (LP-211, 0 or 0.250 mg/kg/day). METHODS: We evaluated behavioural changes as well as forebrain structural/functional modifications by in vivo magnetic resonance (MR) in a 4.7 T system, followed by ex vivo histology. RESULTS: Adult rats pre-treated during adolescence showed reduced anxiety-related behaviour, in terms of reduced avoidance in the light/dark test and a less fragmented pattern of exploration in the novel object recognition test. Diffusion tensor imaging (DTI) revealed decreased mean diffusivity (MD) in the amygdala, increased fractional anisotropy (FA) in the hippocampus (Hip) and reduced axial (D||) together with increased radial (D⊥) diffusivity in the nucleus accumbens (NAcc). An increased neural dendritic arborization was confirmed in the NAcc by ex vivo histology. Seed-based functional MR imaging (fMRI) identified increased strength of connectivity within and between "limbic" and "cortical" loops, with affected cross-correlations between amygdala, NAcc and Hip. The latter displayed enhanced connections through the dorsal striatum (dStr) to dorso-lateral prefrontal cortex (dl-PFC) and cerebellum. Functional connection also increased between amygdala and limbic elements such as NAcc, orbito-frontal cortex (OFC) and hypothalamus. MR spectroscopy (1H-MRS) indicated that adolescent LP-211 exposure increased glutamate and total creatine in the adult Hip. CONCLUSIONS: Persistent MR-detectable modifications indicate a rearrangement within forebrain networks, accounting for long-lasting behavioural changes as a function of developmental 5-HT7-R stimulation.
RATIONALE: The serotonin 7 receptor (5-HT7-R) is part of a neuro-transmission system with a proposed role in neural plasticity and in mood, cognitive or sleep regulation. OBJECTIVES: We investigated long-term consequences of sub-chronic treatment, during adolescence (43-45 to 47-49 days old) in rats, with a novel 5-HT7-R agonist (LP-211, 0 or 0.250 mg/kg/day). METHODS: We evaluated behavioural changes as well as forebrain structural/functional modifications by in vivo magnetic resonance (MR) in a 4.7 T system, followed by ex vivo histology. RESULTS: Adult rats pre-treated during adolescence showed reduced anxiety-related behaviour, in terms of reduced avoidance in the light/dark test and a less fragmented pattern of exploration in the novel object recognition test. Diffusion tensor imaging (DTI) revealed decreased mean diffusivity (MD) in the amygdala, increased fractional anisotropy (FA) in the hippocampus (Hip) and reduced axial (D||) together with increased radial (D⊥) diffusivity in the nucleus accumbens (NAcc). An increased neural dendritic arborization was confirmed in the NAcc by ex vivo histology. Seed-based functional MR imaging (fMRI) identified increased strength of connectivity within and between "limbic" and "cortical" loops, with affected cross-correlations between amygdala, NAcc and Hip. The latter displayed enhanced connections through the dorsal striatum (dStr) to dorso-lateral prefrontal cortex (dl-PFC) and cerebellum. Functional connection also increased between amygdala and limbic elements such as NAcc, orbito-frontal cortex (OFC) and hypothalamus. MR spectroscopy (1H-MRS) indicated that adolescent LP-211 exposure increased glutamate and total creatine in the adult Hip. CONCLUSIONS: Persistent MR-detectable modifications indicate a rearrangement within forebrain networks, accounting for long-lasting behavioural changes as a function of developmental 5-HT7-R stimulation.
Authors: Eva María Marco; Walter Adriani; Rossella Canese; Franca Podo; Maria Paz Viveros; Giovanni Laviola Journal: Pharmacol Biochem Behav Date: 2006-11-13 Impact factor: 3.533
Authors: Christopher P Pawela; Bharat B Biswal; Younghoon R Cho; Dennis S Kao; Rupeng Li; Seth R Jones; Marie L Schulte; Hani S Matloub; Anthony G Hudetz; James S Hyde Journal: Magn Reson Med Date: 2008-05 Impact factor: 4.668
Authors: Judith D Schaechter; Zachary P Fricker; Katherine L Perdue; Karl G Helmer; Mark G Vangel; Douglas N Greve; Nikos Makris Journal: Hum Brain Mapp Date: 2009-11 Impact factor: 5.038
Authors: Filippo Andreetta; Lucia Carboni; Gillian Grafton; Ross Jeggo; Andrew D Whyment; Marco van den Top; Daniel Hoyer; David Spanswick; Nicholas M Barnes Journal: Br J Pharmacol Date: 2016-03-21 Impact factor: 8.739
Authors: Bianca De Filippis; Valentina Chiodi; Walter Adriani; Enza Lacivita; Cinzia Mallozzi; Marcello Leopoldo; Maria Rosaria Domenici; Andrea Fuso; Giovanni Laviola Journal: Front Behav Neurosci Date: 2015-04-14 Impact factor: 3.558
Authors: Adam S Hogendorf; Agata Hogendorf; Rafał Kurczab; Grzegorz Satała; Tomasz Lenda; Maria Walczak; Gniewomir Latacz; Jadwiga Handzlik; Katarzyna Kieć-Kononowicz; Joanna M Wierońska; Monika Woźniak; Paulina Cieślik; Ryszard Bugno; Jakub Staroń; Andrzej J Bojarski Journal: Sci Rep Date: 2017-05-04 Impact factor: 4.379